• Array


Our Development Partner Benchmark Holdings PLC

To develop HypoPet’s novel idea a further step was taken when it entered into a commercialization, manufacture, and distribution agreement with the U.K. based company Benchmark Holdings PLC.

“We have always looked for synergistic opportunities that require the support of our skill sets, science and technology base, and our production capacity. The combination of HypoPet’s highly innovative technology with our world-leading manufacturing and distribution experience in the animal health market, make this agreement a ground-breaking next step within the animal medicines and vaccines space.” – MALCOLM PYE, CEO OF BENCHMARK